Insights

CJEU confirms orphan drug market exclusivity

by Matthew Royle, Ph.D.

Biosimilars and the issue of duplicates

by Dr Paul England and Matthew Royle, Ph.D.

“E-Health Law” in Germany

by Dr. Wolfgang Rehmann

Intellectual Property in the Life Sciences, in review

by Dr Paul England

Setting the record straight - employee background checks

by Paul Callaghan

Three recent cases concerning early conciliation

by Kathryn Clapp

The UK backs the UPC and Unitary Patent

by Dr Paul England

Life sciences issues in Corporate transactions - Part 2

by Colin McCall

The implementation of the Nagoya Protocol in the EU

by Verena Bertram

Fundamental changes to insurance contract law: The Insurance Act 2015

Life Sciences Issues in Corporate Transactions - Part 1

by Colin McCall